从纳米体补充确定区域2 (CDR2) 衍生的的计算建模和表征,针对β2-上腺素受体 (β2AR) 的活性状态构造
Milan Sencanski1,2, Sanja Glisic2, Valentina Kubale3
1Laboratory for Plant Molecular Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11000 Belgrade, Serbia.
Biomolecules
|April 27, 2024
概括
这项研究开发了针对活性β2-上腺素受体 (β2AR) 的纳米体衍生 (NDPs). P4选择性地与激活的β2AR结合,并抑制Gαs信号传递.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- β2上腺素受体 (β2AR) 在生理过程中起着至关重要的作用.
- 针对特定的受体构造,如活性状态,是选择性药物开发的关键.
- 纳米体 (Nbs) 为治疗应用提供了独特的结构特征.
研究的目的:
- 评估纳米体互补性确定区域2 (CDR2) 作为纳米体衍生 (NDP) 的模板的适用性.
- 开发针对活性状态β2AR结构的NDP.
- 描述一种新型CDR2-NDP的结合和信号干扰.
主要方法:
- 信息频谱方法 (ISM) 用于Nb序列分析.
- 蛋白质对接和分子动力学 (MD) 模拟.
- 基于元动力学的自由能量结合计算.
- 在体外测定包括cAMP和基于BRET2的招募测定.
主要成果:
- 一个25-氨基酸CDR2-NDP,P4,被确定具有 -6.8 ± 0.8 kcal/mol的结合自由能量 (ΔG).
- P4证明了与激素激活β2AR的优先结合.
- 在体外,P4抑制了异二醇诱导的cAMP水平,并降低了异二醇的强度,而不影响β-arrestin-2相互作用.
结论:
- 纳米体的CDR2可以作为一种可行的模板,用于导出形状选择性.
- 开发的NDP,P4,选择性地准和对抗β2AR的活性状态.
- P4破坏了Gαs介导的信号传输,为β2AR调节提供了潜在的治疗策略.
相关概念视频
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Structure-Activity Relationships and Drug Design
708
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
708
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Adrenergic Receptors (Adrenoceptors): Classification
2.5K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.5K


